Cough Reflex Sensitivity Improves with Speech Language Pathology Management of Refractory Chronic Cough

Overview

Journal Cough

Publisher Biomed Central

Date 2010 Jul 29

PMID 20663225

Citations 32

Authors

Nicole M Ryan

Anne E Vertigan

Sarah Bone

Peter G Gibson

Affiliations

Soon will be listed here.

Abstract

Rationale: Speech language pathology is an effective management intervention for chronic cough that persists despite medical treatment. The mechanism behind the improvement has not been determined but may include active cough suppression, reduced cough sensitivity or increased cough threshold from reduced laryngeal irritation. Objective measures such as cough reflex sensitivity and cough frequency could be used to determine whether the treatment response was due to reduced underlying cough sensitivity or to more deliberate control exerted by individual patients. The number of treatments required to effect a response was also assessed.

Objective: The aim of this study was to investigate subjective and objective measures of cough before, during and after speech language pathology treatment for refractory chronic cough and the mechanism underlying the improvement.

Methods: Adults with chronic cough (n = 17) were assessed before, during and after speech language pathology intervention for refractory chronic cough. The primary outcome measures were capsaicin cough reflex sensitivity, automated cough frequency detection and cough-related quality of life.

Results: Following treatment there was a significant improvement in cough related quality of life (Median (IQR) at baseline: 13.5 (6.3) vs. post treatment: 16.9 (4.9), p = 0.002), objective cough frequency (Mean +/- SD at baseline: 72.5 +/- 55.8 vs. post treatment: 25 +/- 27.9 coughs/hr, p = 0.009), and cough reflex sensitivity (Mean +/- SD log C5 at baseline: 0.88 +/- 0.48 vs. post treatment: 1.65 +/- 0.88, p < 0.0001).

Conclusions: This is the first study to show that speech language pathology management is an effective intervention for refractory chronic cough and that the mechanism behind the improvement is due to reduced laryngeal irritation which results in decreased cough sensitivity, decreased urge to cough and an increased cough threshold. Speech language pathology may be a useful and sustained treatment for refractory chronic cough.

Trial Registration: Australian New Zealand Clinical Trials Register, ACTRN12608000284369.

Citing Articles

Reframing Refractory Chronic Cough: The Role of Interoception.

Slovarp L, Reynolds J, Gillespie A, Jette M Lung. 2025; 203(1):32.

PMID: 39937307 PMC: 11821735. DOI: 10.1007/s00408-025-00786-7.

Efficacy of behavioral cough suppression therapy for refractory chronic cough or unexplained chronic cough: a meta-analysis of randomized controlled trials.

Yi B, Wang S, Xu X, Yu L Ther Adv Respir Dis. 2024; 18:17534666241305952.

PMID: 39707881 PMC: 11663276. DOI: 10.1177/17534666241305952.

Patient-centered care in pulmonary fibrosis: access, anticipate, and act.

Hofman D, Magri T, Moor C, Richeldi L, Wijsenbeek M, Waseda Y Respir Res. 2024; 25(1):395.

PMID: 39487454 PMC: 11531140. DOI: 10.1186/s12931-024-02997-7.

Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects.

Spinou A, Lee A, ONeil B, Oliveira A, Shteinberg M, Herrero-Cortina B Eur Respir Rev. 2024; 33(174).

PMID: 39477356 PMC: 11522970. DOI: 10.1183/16000617.0087-2024.

Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey.

Khan S, Brister D, Abraham T, Laventure S, Sahakian S, Julia B PLoS One. 2024; 19(8):e0308275.

PMID: 39088459 PMC: 11293633. DOI: 10.1371/journal.pone.0308275.

References

Hutchings H, Eccles R, Smith A, Jawad M . Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections. Eur Respir J. 1993; 6(10):1449-54. View

Matos S, Birring S, Pavord I, Evans D . An automated system for 24-h monitoring of cough frequency: the leicester cough monitor. IEEE Trans Biomed Eng. 2007; 54(8):1472-9. DOI: 10.1109/TBME.2007.900811. View

Carr M, Undem B . Pharmacology of vagal afferent nerve activity in guinea pig airways. Pulm Pharmacol Ther. 2003; 16(1):45-52. DOI: 10.1016/S1094-5539(02)00179-7. View

Vertigan A, Theodoros D, Gibson P, Winkworth A . Voice and upper airway symptoms in people with chronic cough and paradoxical vocal fold movement. J Voice. 2006; 21(3):361-83. DOI: 10.1016/j.jvoice.2005.12.008. View

Dicpinigaitis P, Rauf K . The influence of gender on cough reflex sensitivity. Chest. 1998; 113(5):1319-21. DOI: 10.1378/chest.113.5.1319. View

Oates J, Russell A . Learning voice analysis using an interactive multi-media package: development and preliminary evaluation. J Voice. 1999; 12(4):500-12. DOI: 10.1016/s0892-1997(98)80059-3. View

Morice A, Geppetti P . Cough. 5: The type 1 vanilloid receptor: a sensory receptor for cough. Thorax. 2004; 59(3):257-8. PMC: 1746975. DOI: 10.1136/thx.2003.013482. View

McGarvey L . Idiopathic chronic cough: a real disease or a failure of diagnosis?. Cough. 2005; 1:9. PMC: 1277011. DOI: 10.1186/1745-9974-1-9. View

Haque R, Usmani O, Barnes P . Chronic idiopathic cough: a discrete clinical entity?. Chest. 2005; 127(5):1710-3. DOI: 10.1378/chest.127.5.1710. View

10.

Locke G, Talley N, Weaver A, Zinsmeister A . A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994; 69(6):539-47. DOI: 10.1016/s0025-6196(12)62245-9. View

11.

IRWIN R, Madison J . The diagnosis and treatment of cough. N Engl J Med. 2000; 343(23):1715-21. DOI: 10.1056/NEJM200012073432308. View

12.

Birring S, Fleming T, Matos S, Raj A, Evans D, Pavord I . The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J. 2008; 31(5):1013-8. DOI: 10.1183/09031936.00057407. View

13.

Pratter M . Unexplained (idiopathic) cough: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl):220S-221S. DOI: 10.1378/chest.129.1_suppl.220S. View

14.

Dicpinigaitis P . Short- and long-term reproducibility of capsaicin cough challenge testing. Pulm Pharmacol Ther. 2003; 16(1):61-5. DOI: 10.1016/S1094-5539(02)00149-9. View

15.

Vertigan A, Theodoros D, Gibson P, Winkworth A . Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax. 2006; 61(12):1065-9. PMC: 2117063. DOI: 10.1136/thx.2006.064337. View

16.

Fujimura M, Kasahara K, Kamio Y, Naruse M, Hashimoto T, Matsuda T . Female gender as a determinant of cough threshold to inhaled capsaicin. Eur Respir J. 1996; 9(8):1624-6. DOI: 10.1183/09031936.96.09081624. View

17.

Ryan N, Vertigan A, Gibson P . Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough. 2009; 5:4. PMC: 2664779. DOI: 10.1186/1745-9974-5-4. View

18.

Kastelik J, Aziz I, Ojoo J, Thompson R, Redington A, Morice A . Investigation and management of chronic cough using a probability-based algorithm. Eur Respir J. 2005; 25(2):235-43. DOI: 10.1183/09031936.05.00140803. View

19.

Midgren B, Hansson L, Karlsson J, SIMONSSON B, Persson C . Capsaicin-induced cough in humans. Am Rev Respir Dis. 1992; 146(2):347-51. DOI: 10.1164/ajrccm/146.2.347. View

20.

Hutchings H, Morris S, Eccles R, Jawad M . Voluntary suppression of cough induced by inhalation of capsaicin in healthy volunteers. Respir Med. 1993; 87(5):379-82. DOI: 10.1016/0954-6111(93)90052-2. View